217 related articles for article (PubMed ID: 12917351)
1. A novel domain in adenovirus L4-100K is required for stable binding and efficient inhibition of human granzyme B: possible interaction with a species-specific exosite.
Andrade F; Casciola-Rosen LA; Rosen A
Mol Cell Biol; 2003 Sep; 23(17):6315-26. PubMed ID: 12917351
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus L4-100K assembly protein is a granzyme B substrate that potently inhibits granzyme B-mediated cell death.
Andrade F; Bull HG; Thornberry NA; Ketner GW; Casciola-Rosen LA; Rosen A
Immunity; 2001 Jun; 14(6):751-61. PubMed ID: 11420045
[TBL] [Abstract][Full Text] [Related]
3. The three-dimensional structure of human granzyme B compared to caspase-3, key mediators of cell death with cleavage specificity for aspartic acid in P1.
Rotonda J; Garcia-Calvo M; Bull HG; Geissler WM; McKeever BM; Willoughby CA; Thornberry NA; Becker JW
Chem Biol; 2001 Apr; 8(4):357-68. PubMed ID: 11325591
[TBL] [Abstract][Full Text] [Related]
4. Granzymes: a family of lymphocyte granule serine proteases.
Trapani JA
Genome Biol; 2001; 2(12):REVIEWS3014. PubMed ID: 11790262
[TBL] [Abstract][Full Text] [Related]
5. Arginine methylation of human adenovirus type 5 L4 100-kilodalton protein is required for efficient virus production.
Koyuncu OO; Dobner T
J Virol; 2009 May; 83(10):4778-90. PubMed ID: 19264777
[TBL] [Abstract][Full Text] [Related]
6. The structure of the pro-apoptotic protease granzyme B reveals the molecular determinants of its specificity.
Waugh SM; Harris JL; Fletterick R; Craik CS
Nat Struct Biol; 2000 Sep; 7(9):762-5. PubMed ID: 10966646
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis induced by granzyme B-glycosaminoglycan complexes: implications for granule-mediated apoptosis in vivo.
Galvin JP; Spaeny-Dekking LH; Wang B; Seth P; Hack CE; Froelich CJ
J Immunol; 1999 May; 162(9):5345-50. PubMed ID: 10228010
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of the caspase activator human granzyme B, a proteinase highly specific for an Asp-P1 residue.
Estébanez-Perpiña E; Fuentes-Prior P; Belorgey D; Braun M; Kiefersauer R; Maskos K; Huber R; Rubin H; Bode W
Biol Chem; 2000 Dec; 381(12):1203-14. PubMed ID: 11209755
[TBL] [Abstract][Full Text] [Related]
9. Importance of the P4' residue in human granzyme B inhibitors and substrates revealed by scanning mutagenesis of the proteinase inhibitor 9 reactive center loop.
Sun J; Whisstock JC; Harriott P; Walker B; Novak A; Thompson PE; Smith AI; Bird PI
J Biol Chem; 2001 May; 276(18):15177-84. PubMed ID: 11278311
[TBL] [Abstract][Full Text] [Related]
10. Granzymes (lymphocyte serine proteases): characterization with natural and synthetic substrates and inhibitors.
Kam CM; Hudig D; Powers JC
Biochim Biophys Acta; 2000 Mar; 1477(1-2):307-23. PubMed ID: 10708866
[TBL] [Abstract][Full Text] [Related]
11. Granule-mediated killing: pathways for granzyme B-initiated apoptosis.
Talanian RV; Yang X; Turbov J; Seth P; Ghayur T; Casiano CA; Orth K; Froelich CJ
J Exp Med; 1997 Oct; 186(8):1323-31. PubMed ID: 9334372
[TBL] [Abstract][Full Text] [Related]
12. Granzyme M is a regulatory protease that inactivates proteinase inhibitor 9, an endogenous inhibitor of granzyme B.
Mahrus S; Kisiel W; Craik CS
J Biol Chem; 2004 Dec; 279(52):54275-82. PubMed ID: 15494398
[TBL] [Abstract][Full Text] [Related]
13. Subsite specificities of granzyme M: a study of inhibitors and newly synthesized thiobenzyl ester substrates.
Rukamp BJ; Kam CM; Natarajan S; Bolton BW; Smyth MJ; Kelly JM; Powers JC
Arch Biochem Biophys; 2004 Feb; 422(1):9-22. PubMed ID: 14725853
[TBL] [Abstract][Full Text] [Related]
14. Granzyme B-mediated degradation of T-cell receptor zeta chain.
Wieckowski E; Wang GQ; Gastman BR; Goldstein LA; Rabinowich H
Cancer Res; 2002 Sep; 62(17):4884-9. PubMed ID: 12208735
[TBL] [Abstract][Full Text] [Related]
15. Granzymes: a variety of serine protease specificities encoded by genetically distinct subfamilies.
Smyth MJ; O'Connor MD; Trapani JA
J Leukoc Biol; 1996 Nov; 60(5):555-62. PubMed ID: 8929545
[TBL] [Abstract][Full Text] [Related]
16. Prime site binding inhibitors of a serine protease: NS3/4A of hepatitis C virus.
Ingallinella P; Fattori D; Altamura S; Steinkühler C; Koch U; Cicero D; Bazzo R; Cortese R; Bianchi E; Pessi A
Biochemistry; 2002 Apr; 41(17):5483-92. PubMed ID: 11969409
[TBL] [Abstract][Full Text] [Related]
17. Human and murine cytotoxic T lymphocyte serine proteases: subsite mapping with peptide thioester substrates and inhibition of enzyme activity and cytolysis by isocoumarins.
Odake S; Kam CM; Narasimhan L; Poe M; Blake JT; Krahenbuhl O; Tschopp J; Powers JC
Biochemistry; 1991 Feb; 30(8):2217-27. PubMed ID: 1998680
[TBL] [Abstract][Full Text] [Related]
18. Definition and redesign of the extended substrate specificity of granzyme B.
Harris JL; Peterson EP; Hudig D; Thornberry NA; Craik CS
J Biol Chem; 1998 Oct; 273(42):27364-73. PubMed ID: 9765264
[TBL] [Abstract][Full Text] [Related]
19. Direct cleavage of the human DNA fragmentation factor-45 by granzyme B induces caspase-activated DNase release and DNA fragmentation.
Sharif-Askari E; Alam A; Rhéaume E; Beresford PJ; Scotto C; Sharma K; Lee D; DeWolf WE; Nuttall ME; Lieberman J; Sékaly RP
EMBO J; 2001 Jun; 20(12):3101-13. PubMed ID: 11406587
[TBL] [Abstract][Full Text] [Related]
20. Molecular Mechanism of Adenovirus Late Protein L4-100K Chaperones the Trimerization of Hexon.
Zhu R; Xu XG; Zhang TX; Wang XP; Zhang CH; Wang CY; Wang C; Wu JX; Yu B; Yu XH
J Virol; 2023 Jan; 97(1):e0146722. PubMed ID: 36475768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
